In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid, and peroxyl radicals.

Mounting evidence supports current theories linking lipoprotein oxidation to atherosclerosis. We sought the cellular biochemical mechanism by which oxidized LDL inflicts cell injury. Inhibitors of candidate pathways of cell death were used to treat human fibroblast target cells exposed to oxidized LDL.. Ebselen, which degrades lipid hydroperoxides, inhibited oxidized LDL toxicity, consistent with our recent report that 7 beta-hydroperoxycholesterol (7 beta-OOH chol) is the major cytotoxin of oxidized LDL. Intracellular chelation of metal ions inhibited, while preloading cells with iron enhanced, toxicity, Inhibition of oxidized LDL and 7 beta-OOH chol toxicity by 2-keto-4-thiolmethyl butyric acid, a putative alkoxyl radical scavenger and by vitamin E, probucol and diphenylphenylenediamine, putative scavengers of peroxyl radicals was consistent with the involvement of these radicals in the lethal sequence. Cell death was thus postulated to occur due to lipid peroxidation via a sequence involving lipid hydroperoxide-induced, iron-mediated formation of alkoxyl, lipid, and peroxyl radicals. Pathways involving other reactive oxygen species, new protein synthesis, or altered cholesterol metabolism were considered less likely, since putative inhibitors failed to lessen toxicity. Understanding the mechanism of cell injury by oxidized LDL and its toxic moiety, 7 beta-OOH chol, may indicate specific interventions in the cell injury believed to accompany vascular lesion development.

[1]  D. Morel,et al.  7 beta-hydroperoxycholest-5-en-3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Penn,et al.  Oxidized lipoproteins, altered cell function and atherosclerosis. , 1994, Atherosclerosis.

[3]  J. Guyton,et al.  Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[4]  J. Farber,et al.  Differing effects of the inhibition of poly(ADP-ribose) polymerase on the course of oxidative cell injury in hepatocytes and fibroblasts. , 1993, Biochemical pharmacology.

[5]  M. Hess,et al.  Protective effects of histidine during ischemia-reperfusion in isolated perfused rat hearts. , 1993, The American journal of physiology.

[6]  H. Sies Ebselen, a selenoorganic compound as glutathione peroxidase mimic. , 1993, Free radical biology & medicine.

[7]  A. Girotti,et al.  Lethal damage to endothelial cells by oxidized low density lipoprotein: role of selenoperoxidases in cytoprotection against lipid hydroperoxide- and iron-mediated reactions. , 1993, Journal of lipid research.

[8]  G. Minotti Sources and role of iron in lipid peroxidation. , 1993, Chemical research in toxicology.

[9]  R. Klausner,et al.  Regulating the fate of mRNA: The control of cellular iron metabolism , 1993, Cell.

[10]  G. Lescoat,et al.  Antioxidant and free radical scavenging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones in iron-loaded hepatocyte cultures: comparison of their mechanism of protection with that of desferrioxamine. , 1992, Free radical biology & medicine.

[11]  W. Stahl,et al.  Antioxidant Functions of Vitamins , 1992, Annals of the New York Academy of Sciences.

[12]  S. Sen PROGRAMMED CELL DEATH: CONCEPT, MECHANISM AND CONTROL , 1992, Biological reviews of the Cambridge Philosophical Society.

[13]  Y. Yamamoto,et al.  Action of ebselen as an antioxidant against lipid peroxidation. , 1992, Biochemical pharmacology.

[14]  F. Ursini,et al.  Antioxidant effect of Ebselen (PZ 51): peroxidase mimetic activity on phospholipid and cholesterol hydroperoxides vs free radical scavenger activity. , 1992, Archives of biochemistry and biophysics.

[15]  S. Hahn,et al.  The catecholic metal sequestering agent 1,2-dihydroxybenzene-3,5-disulfonate confers protection against oxidative cell damage. , 1992, Archives of biochemistry and biophysics.

[16]  G. Chisolm Cytotoxicity of oxidized lipoproteins , 1991 .

[17]  A. Nègre-Salvayre,et al.  Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. III. The protective effect of antioxidants (probucol, catechin, vitamin E) against the cytotoxicity of oxidized LDL occurs in two different ways. , 1991, Biochimica et biophysica acta.

[18]  M. Freeman,et al.  Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Kuzuya,et al.  Probucol prevents oxidative injury to endothelial cells. , 1991, Journal of lipid research.

[20]  M. Kuzuya,et al.  Involvement of intracellular iron in the toxicity of oxidized low density lipoprotein to cultured endothelial cells. , 1990, Biochemistry international.

[21]  A. Nègre-Salvayre,et al.  Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cell. I. Chemical modifications of ultraviolet-treated low-density lipoproteins. , 1990, Biochimica et biophysica acta.

[22]  D. Morel,et al.  Activated human monocytes oxidize low-density lipoprotein by a lipoxygenase-dependent pathway. , 1990, Journal of immunology.

[23]  J. Farber,et al.  Mechanisms of cell injury by activated oxygen species. , 1994, Environmental health perspectives.

[24]  G. Chisolm,et al.  Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-alpha mRNA in stimulated murine peritoneal macrophages. , 1990, Journal of immunology.

[25]  A. Nègre-Salvayre,et al.  [The cytotoxicity of oxidized lipoproteins]. , 1989, Bulletin de l'Academie nationale de medecine.

[26]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[27]  J. Farber,et al.  tert-butyl hydroperoxide kills cultured hepatocytes by peroxidizing membrane lipids. , 1989, Archives of biochemistry and biophysics.

[28]  D. Steinberg,et al.  A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[29]  W. Pryor,et al.  Comparison of the Efficiencies of Several Natural and Synthetic Antioxidants in Aqueous Sodium Dodecyl Sulfate Micelle Solutions , 1988 .

[30]  W. Pryor,et al.  Comparison of the efficiencies of several natural and synthetic antioxidants in aqueous SDS [sodium dodecyl sulfate] micelle solutions , 1988 .

[31]  G. Chisolm,et al.  Modification of human serum low density lipoprotein by oxidation--characterization and pathophysiological implications. , 1987, Chemistry and physics of lipids.

[32]  G. Chisolm,et al.  Lipoprotein-mediated inhibition of endothelial cell production of platelet-derived growth factor-like protein depends on free radical lipid peroxidation. , 1987, The Journal of biological chemistry.

[33]  D. Morel,et al.  Toxicity of oxidized low‐density lipoprotein to cultured fibroblasts is selective for S phase of the cell cycle , 1987, Journal of cellular physiology.

[34]  L. Sklar,et al.  Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Ross The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[36]  A. Wendel,et al.  A novel biologically active seleno-organic compound--V. Inhibition by ebselen (PZ 51) of rat peritoneal neutrophil lipoxygenase. , 1985, Biochemical pharmacology.

[37]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[38]  G. Krishna,et al.  A simple and sensitive method for monitoring drug-induced cell injury in cultured cells. , 1985, Analytical biochemistry.

[39]  B. Halliwell,et al.  Oxygen toxicity, oxygen radicals, transition metals and disease. , 1984, The Biochemical journal.

[40]  A. Cederbaum,et al.  The generation of hydroxyl and alkoxyl radicals from the interaction of ferrous bipyridyl with peroxides. , 1983, The Biochemical journal.

[41]  M. Astruc,et al.  DNA and cholesterol biosynthesis in synchronized embryonic rat fibroblasts. I. Temporal relationships between HMG-CoA reductase activity, sterol biosynthesis and thymidine incorporation into DNA. , 1983, Biochimica et biophysica acta.

[42]  D. Morel,et al.  Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. , 1983, Journal of lipid research.

[43]  T. Kensler,et al.  Inhibition of tumor promotion by a biomimetic superoxide dismutase. , 1983, Science.

[44]  L. J. Lewis,et al.  Lipoprotein Oxidation and Lipoprotein‐lnduced Cytotoxicity , 1983, Arteriosclerosis.

[45]  L. Oberley,et al.  Antitumor effect of a copper coordination compound with superoxide dismutase-like activity. , 1981, Journal of the National Cancer Institute.

[46]  G. Chisolm,et al.  Measurements of the degradation products of radioiodinated proteins. , 1981, Analytical biochemistry.

[47]  T. Henriksen,et al.  Injury to human endothelial cells in culture induced by low density lipoproteins. , 1979, Scandinavian journal of clinical and laboratory investigation.

[48]  G. Chisolm,et al.  LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. , 1979, Atherosclerosis.

[49]  R H Haschemeyer,et al.  Oxygen-mediated heterogeneity of apo-low-density lipoprotein. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Brown,et al.  Suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and inhibition of growth of human fibroblasts by 7-ketocholesterol. , 1974, The Journal of biological chemistry.

[51]  E. B. Smith,et al.  Relationship between low-density lipoprotein in aortic intima and serum-lipid levels. , 1972, Lancet.

[52]  A. Mcfarlane,et al.  Efficient Trace-labelling of Proteins with Iodine , 1958, Nature.

[53]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[54]  D. Liebler The role of metabolism in the antioxidant function of vitamin E. , 1993, Critical reviews in toxicology.

[55]  J. Aikens,et al.  Mechanisms and biological relevance of lipid peroxidation initiation. , 1993, Chemical research in toxicology.

[56]  A. Nègre-Salvayre,et al.  Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines. , 1992, Free radical biology & medicine.

[57]  J. Eaton,et al.  Iron loading of endothelial cells augments oxidant damage. , 1990, The Journal of laboratory and clinical medicine.

[58]  D. Steinberg,et al.  Lipoproteins in normal and atherosclerotic aorta. , 1990, European heart journal.

[59]  T. Henriksen,et al.  Injury to human cells in culture induced by low density lipoprotein: an effect independent of receptor binding and endocytotic uptake of low density lipoprotein. , 1982, Scandinavian journal of clinical and laboratory investigation.

[60]  T. Henriksen,et al.  Injury to cultured endothelial cells induced by low density lipoproteins: protection by high density lipoproteins. , 1979, Scandinavian journal of clinical and laboratory investigation.

[61]  Z. Werb,et al.  CHOLESTEROL METABOLISM IN THE MACROPHAGE III. INGESTION AND INTRACELLULAR FATE OF CHOLESTEROL AND CHOLESTEROL ESTERS , 1972 .

[62]  F. Hatch Practical methods for plasma lipoprotein analysis. , 1968, Advances in lipid research.